RA CAPITAL MANAGEMENT, L.P. has filed 320 insider transactions across 29 companies since January 2023.
Most recent transaction: a purchase of 58300 shares of Mineralys Therapeutics, Inc. ($MLYS) on March 30, 2026.
Activity breakdown: 76 open-market purchases and 77 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 30, 2026 | Mineralys Therapeutics, Inc. | $MLYS | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 58300 | $24.16 | 7,692,750.0000 | 79,139,956 | 0.76% | 0.07% |
| March 27, 2026 | Mineralys Therapeutics, Inc. | $MLYS | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 310700 | $23.67 | 7,634,450.0000 | 79,139,956 | 4.24% | 0.39% |
| March 26, 2026 | Wave Life Sciences Ltd. | $WVE | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Ordinary Shares | 4954558 | $6.06 | 23,186,382.0000 | 167,739,208 | 27.18% | 2.95% |
| March 30, 2026 | Wave Life Sciences Ltd. | $WVE | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Ordinary Shares | 971091 | $6.50 | 27,004,320.0000 | 167,739,208 | 3.73% | 0.58% |
| March 27, 2026 | Wave Life Sciences Ltd. | $WVE | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Ordinary Shares | 2495623 | $6.43 | 26,033,229.0000 | 167,739,208 | 10.60% | 1.49% |
| March 26, 2026 | Wave Life Sciences Ltd. | $WVE | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Ordinary Shares | 351224 | $6.38 | 23,537,606.0000 | 167,739,208 | 1.51% | 0.21% |
| March 16, 2026 | Acumen Pharmaceuticals, Inc. | $ABOS | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Common Stock | 6060606 | $3.30 | 20,992,669.0000 | 60,573,425 | 40.59% | 10.01% |
| Feb. 26, 2026 | Bicara Therapeutics Inc. | $BCAX | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Pre-Funded Warrant (Right to Buy) | 2200000 | $16.00 | 2,200,000.0000 | 54,563,864 | 9999.99% | 4.03% |
| Feb. 26, 2026 | Bicara Therapeutics Inc. | $BCAX | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 300000 | $16.00 | 7,255,993.0000 | 54,563,864 | 4.31% | 0.55% |
| Feb. 19, 2026 | Mineralys Therapeutics, Inc. | $MLYS | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Common Stock | 6200 | $0.00 | 7,329,950.0000 | 79,139,956 | 0.08% | 0.01% |
| Feb. 19, 2026 | Mineralys Therapeutics, Inc. | $MLYS | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 8300 | $0.00 | 8,300.0000 | 79,139,956 | 9999.99% | 0.01% |
| Feb. 17, 2026 | Evommune, Inc. | $EVMN | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Common Stock | 35868 | $27.88 | 3,494,638.0000 | 31,524,093 | 1.04% | 0.11% |
| Feb. 9, 2026 | SpyGlass Pharma, Inc. | $SGP | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 3441966 | $16.00 | 5,966,439.0000 | 0 | 136.34% | 0.00% |
| Feb. 9, 2026 | SpyGlass Pharma, Inc. | $SGP | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Common Stock | 1806644 | $0.00 | 1,806,644.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2026 | SpyGlass Pharma, Inc. | $SGP | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Common Stock | 2524473 | $0.00 | 2,524,473.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2026 | SpyGlass Pharma, Inc. | $SGP | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series D Preferred Stock | 222591 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 9, 2026 | SpyGlass Pharma, Inc. | $SGP | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series D Preferred Stock | 272056 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 9, 2026 | SpyGlass Pharma, Inc. | $SGP | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series C-1 Preferred Stock | 1150941 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 9, 2026 | SpyGlass Pharma, Inc. | $SGP | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 248034 | $16.00 | 2,054,678.0000 | 0 | 13.73% | 0.00% |
| Feb. 9, 2026 | SpyGlass Pharma, Inc. | $SGP | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series C-2 Preferred Stock | 767294 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 9, 2026 | SpyGlass Pharma, Inc. | $SGP | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series C-2 Preferred Stock | 1150941 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 9, 2026 | SpyGlass Pharma, Inc. | $SGP | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series C-1 Preferred Stock | 767294 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 5, 2026 | SpyGlass Pharma, Inc. | $SGP | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (right to buy) | 27400 | $0.00 | 27,400.0000 | 0 | 9999.99% | 0.00% |
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | RA CAPITAL MANAGEMENT, L.P. | Not found | M | Pre-Funded Warrants (Right to Buy) | 1286786 | $0.00 | 0.0000 | 31,439,371 | 100.00% | 4.09% |
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | RA CAPITAL MANAGEMENT, L.P. | Not found | D | Stock Option (right to buy) | 5079 | $0.00 | 0.0000 | 31,439,371 | 100.00% | 0.02% |
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | RA CAPITAL MANAGEMENT, L.P. | Not found | D | Stock Option (right to buy) | 22200 | $0.00 | 0.0000 | 31,439,371 | 100.00% | 0.07% |
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | RA CAPITAL MANAGEMENT, L.P. | Not found | D | Common Stock | 4652309 | $221.50 | 0.0000 | 31,439,371 | 100.00% | 14.80% |
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | RA CAPITAL MANAGEMENT, L.P. | Not found | M | Common Stock | 1286786 | $0.00 | 4,652,309.0000 | 31,439,371 | 38.23% | 4.09% |
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | RA CAPITAL MANAGEMENT, L.P. | Not found | D | Series A Preferred Stock | 89956 | $15505.00 | 0.0000 | 31,439,371 | 100.00% | 0.29% |
| Jan. 5, 2026 | Climb Bio, Inc. | $CLYM | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 7111 | $3.50 | 11,300,939.0000 | 68,184,435 | 0.06% | 0.01% |
| Dec. 18, 2025 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Common Stock | 4625346 | $10.81 | 5,404,998.0000 | 10,410,630 | 46.11% | 44.43% |
| Dec. 18, 2025 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 3000 | $0.00 | 3,000.0000 | 10,410,630 | 9999.99% | 0.03% |
| Dec. 12, 2025 | Climb Bio, Inc. | $CLYM | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 101462 | $2.86 | 11,293,828.0000 | 68,184,435 | 0.91% | 0.15% |
| Dec. 11, 2025 | Climb Bio, Inc. | $CLYM | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Pre-Funded Warrants (Right to Buy) | 20440000 | $0.00 | 20,440,000.0000 | 68,184,435 | 9999.99% | 29.98% |
| Dec. 11, 2025 | Climb Bio, Inc. | $CLYM | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 213099 | $2.18 | 11,192,366.0000 | 68,184,435 | 1.94% | 0.31% |
| Dec. 11, 2025 | Climb Bio, Inc. | $CLYM | RA CAPITAL MANAGEMENT, L.P. | Not found | D | Common Stock | 20440000 | $0.00 | 10,979,267.0000 | 68,184,435 | 65.06% | 29.98% |
| Dec. 8, 2025 | Fulcrum Therapeutics, Inc. | $FULC | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 1377020 | $13.33 | 8,852,079.0000 | 62,597,000 | 13.46% | 2.20% |
| Dec. 8, 2025 | Fulcrum Therapeutics, Inc. | $FULC | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 91722 | $14.98 | 6,053,960.0000 | 62,597,000 | 1.49% | 0.15% |
| Dec. 8, 2025 | Fulcrum Therapeutics, Inc. | $FULC | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 2706397 | $14.28 | 6,145,682.0000 | 62,597,000 | 30.57% | 4.32% |
| Nov. 20, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 788 | $40.50 | 660,231.0000 | 44,628,788 | 0.12% | 0.00% |
| Nov. 20, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 512 | $40.50 | 2,204,522.0000 | 44,628,788 | 0.02% | 0.00% |
| Nov. 20, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 150 | $39.89 | 6,898,929.0000 | 44,628,788 | 0.00% | 0.00% |
| Nov. 20, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 604 | $40.50 | 166,642.0000 | 44,628,788 | 0.36% | 0.00% |
| Nov. 21, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 1210 | $39.50 | 6,897,623.0000 | 44,628,788 | 0.02% | 0.00% |
| Nov. 21, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 9924 | $39.50 | 650,307.0000 | 44,628,788 | 1.50% | 0.02% |
| Nov. 20, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 1235 | $39.89 | 661,019.0000 | 44,628,788 | 0.19% | 0.00% |
| Nov. 21, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 6440 | $39.50 | 2,198,082.0000 | 44,628,788 | 0.29% | 0.01% |
| Nov. 20, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 947 | $39.89 | 167,246.0000 | 44,628,788 | 0.56% | 0.00% |
| Nov. 20, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 801 | $39.89 | 2,205,034.0000 | 44,628,788 | 0.04% | 0.00% |
| Nov. 21, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 7609 | $39.50 | 159,033.0000 | 44,628,788 | 4.57% | 0.02% |
| Nov. 20, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 96 | $40.50 | 6,898,833.0000 | 44,628,788 | 0.00% | 0.00% |
| Nov. 17, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 17913 | $40.20 | 698,075.0000 | 44,628,788 | 2.50% | 0.04% |
| Nov. 17, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 53 | $42.10 | 6,901,689.0000 | 44,628,788 | 0.00% | 0.00% |
| Nov. 17, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 9063 | $41.05 | 2,220,019.0000 | 44,628,788 | 0.41% | 0.02% |
| Nov. 17, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 13964 | $41.05 | 684,111.0000 | 44,628,788 | 2.00% | 0.03% |
| Nov. 17, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 10707 | $41.05 | 184,950.0000 | 44,628,788 | 5.47% | 0.02% |
| Nov. 17, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 2182 | $40.20 | 6,903,443.0000 | 44,628,788 | 0.03% | 0.00% |
| Nov. 19, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 9 | $40.61 | 168,193.0000 | 44,628,788 | 0.01% | 0.00% |
| Nov. 19, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 8 | $40.61 | 2,205,835.0000 | 44,628,788 | 0.00% | 0.00% |
| Nov. 19, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 12 | $40.61 | 662,254.0000 | 44,628,788 | 0.00% | 0.00% |
| Nov. 19, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 2 | $40.61 | 6,899,079.0000 | 44,628,788 | 0.00% | 0.00% |
| Nov. 19, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 14325 | $40.01 | 168,202.0000 | 44,628,788 | 7.85% | 0.03% |
| Nov. 19, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 12126 | $40.01 | 2,205,843.0000 | 44,628,788 | 0.55% | 0.03% |
| Nov. 19, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 18684 | $40.01 | 662,266.0000 | 44,628,788 | 2.74% | 0.04% |
| Nov. 19, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 2276 | $40.01 | 6,899,081.0000 | 44,628,788 | 0.03% | 0.01% |
| Nov. 18, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 2092 | $39.57 | 182,527.0000 | 44,628,788 | 1.13% | 0.00% |
| Nov. 18, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 1770 | $39.57 | 2,217,969.0000 | 44,628,788 | 0.08% | 0.00% |
| Nov. 18, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 2728 | $39.57 | 680,950.0000 | 44,628,788 | 0.40% | 0.01% |
| Nov. 18, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 332 | $39.57 | 6,901,357.0000 | 44,628,788 | 0.00% | 0.00% |
| Nov. 17, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 331 | $42.10 | 184,619.0000 | 44,628,788 | 0.18% | 0.00% |
| Nov. 17, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 11626 | $40.20 | 2,229,082.0000 | 44,628,788 | 0.52% | 0.03% |
| Nov. 17, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 280 | $42.10 | 2,219,739.0000 | 44,628,788 | 0.01% | 0.00% |
| Nov. 17, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 433 | $42.10 | 683,678.0000 | 44,628,788 | 0.06% | 0.00% |
| Nov. 17, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 13734 | $40.20 | 195,657.0000 | 44,628,788 | 6.56% | 0.03% |
| Nov. 17, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 1701 | $41.05 | 6,901,742.0000 | 44,628,788 | 0.02% | 0.00% |
| Nov. 13, 2025 | Wave Life Sciences Ltd. | $WVE | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Ordinary Shares | 1000 | $6.69 | 18,231,824.0000 | 167,739,208 | 0.01% | 0.00% |
| Nov. 7, 2025 | Evommune, Inc. | $EVMN | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Common Stock | 691441 | $0.00 | 691,441.0000 | 0 | 9999.99% | 0.00% |
| Nov. 7, 2025 | Evommune, Inc. | $EVMN | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 1157096 | $16.00 | 2,674,425.0000 | 0 | 76.26% | 0.00% |
| Nov. 7, 2025 | Evommune, Inc. | $EVMN | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Common Stock | 1517329 | $0.00 | 1,517,329.0000 | 0 | 9999.99% | 0.00% |
| Nov. 7, 2025 | Evommune, Inc. | $EVMN | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series C Preferred Stock | 12924620 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Evommune, Inc. | $EVMN | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series C Preferred Stock | 5889699 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Evommune, Inc. | $EVMN | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 92904 | $16.00 | 784,345.0000 | 0 | 13.44% | 0.00% |
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | RA CAPITAL MANAGEMENT, L.P. | Not found | D | Stock Option (Right to Buy) | 12500 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.01% |
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | RA CAPITAL MANAGEMENT, L.P. | Not found | D | Stock Option (Right to Buy) | 25000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.02% |
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | RA CAPITAL MANAGEMENT, L.P. | Not found | D | Stock Option (Right to Buy) | 56400 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.04% |
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | RA CAPITAL MANAGEMENT, L.P. | Not found | D | Stock Option (Right to Buy) | 45150 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.03% |
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | RA CAPITAL MANAGEMENT, L.P. | Not found | D | Stock Option (Right to Buy) | 27400 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.02% |
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | RA CAPITAL MANAGEMENT, L.P. | Not found | D | Stock Option (Right to Buy) | 7000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.00% |
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | RA CAPITAL MANAGEMENT, L.P. | Not found | D | Common Stock | 335364 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.21% |
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | RA CAPITAL MANAGEMENT, L.P. | Not found | D | Pre-Funded Warrants (Right to Buy) | 4331081 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 2.74% |
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | RA CAPITAL MANAGEMENT, L.P. | Not found | D | Stock Option (Right to Buy) | 7000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.00% |
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | RA CAPITAL MANAGEMENT, L.P. | Not found | D | Common Stock | 19554319 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 12.39% |
| Oct. 28, 2025 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 87828 | $27.10 | 1,092,232.0000 | 124,851,547 | 7.44% | 0.07% |
| Oct. 28, 2025 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 36483 | $28.18 | 1,055,749.0000 | 124,851,547 | 3.34% | 0.03% |
| Oct. 29, 2025 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 251518 | $25.22 | 804,231.0000 | 124,851,547 | 23.82% | 0.20% |
| Oct. 30, 2025 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 24579 | $25.12 | 779,652.0000 | 124,851,547 | 3.06% | 0.02% |
| Oct. 28, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 17118 | $39.58 | 2,240,708.0000 | 0 | 0.76% | 0.00% |
| Oct. 28, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 10476 | $39.58 | 209,391.0000 | 0 | 4.76% | 0.00% |
| Oct. 28, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 31392 | $39.58 | 715,988.0000 | 0 | 4.20% | 0.00% |
| Oct. 28, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 3624 | $39.58 | 6,905,625.0000 | 0 | 0.05% | 0.00% |
| Oct. 24, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 107941 | $39.50 | 219,867.0000 | 0 | 32.93% | 0.00% |
| Oct. 24, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 66672 | $39.50 | 2,257,826.0000 | 0 | 2.87% | 0.00% |
| Oct. 24, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 122271 | $39.50 | 747,380.0000 | 0 | 14.06% | 0.00% |
| Oct. 24, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 14116 | $39.50 | 6,909,249.0000 | 0 | 0.20% | 0.00% |
| Oct. 24, 2025 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 53345 | $28.01 | 1,271,001.0000 | 124,851,547 | 4.03% | 0.04% |
| Oct. 27, 2025 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 90941 | $28.12 | 1,180,060.0000 | 124,851,547 | 7.16% | 0.07% |
| Oct. 23, 2025 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 76880 | $28.01 | 1,324,346.0000 | 124,851,547 | 5.49% | 0.06% |
| Oct. 21, 2025 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 25027 | $28.11 | 1,401,226.0000 | 124,851,547 | 1.75% | 0.02% |
| Oct. 20, 2025 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 6553 | $30.12 | 1,426,253.0000 | 124,851,547 | 0.46% | 0.01% |
| Oct. 20, 2025 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 13817 | $29.63 | 1,287.0000 | 124,851,547 | 91.48% | 0.01% |
| Oct. 20, 2025 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 70366 | $29.63 | 1,432,806.0000 | 124,851,547 | 4.68% | 0.06% |
| Oct. 20, 2025 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 1287 | $30.12 | 0.0000 | 124,851,547 | 100.00% | 0.00% |
| Oct. 16, 2025 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 3108 | $30.36 | 57,924.0000 | 124,851,547 | 5.09% | 0.00% |
| Oct. 16, 2025 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 20 | $31.35 | 1,721,215.0000 | 124,851,547 | 0.00% | 0.00% |
| Oct. 16, 2025 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 4 | $31.35 | 57,920.0000 | 124,851,547 | 0.01% | 0.00% |
| Oct. 17, 2025 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 174594 | $29.12 | 1,546,621.0000 | 124,851,547 | 10.14% | 0.14% |
| Oct. 17, 2025 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 34284 | $29.12 | 23,636.0000 | 124,851,547 | 59.19% | 0.03% |
| Oct. 17, 2025 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 30758 | $30.28 | 1,515,863.0000 | 124,851,547 | 1.99% | 0.02% |
| Oct. 17, 2025 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 6040 | $30.28 | 17,596.0000 | 124,851,547 | 25.55% | 0.00% |
| Oct. 17, 2025 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 12691 | $31.00 | 1,503,172.0000 | 124,851,547 | 0.84% | 0.01% |
| Oct. 17, 2025 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 2492 | $31.00 | 15,104.0000 | 124,851,547 | 14.16% | 0.00% |
| Oct. 15, 2025 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 8384 | $30.55 | 82,882.0000 | 124,851,547 | 9.19% | 0.01% |
| Oct. 15, 2025 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 42699 | $30.55 | 1,848,336.0000 | 124,851,547 | 2.26% | 0.03% |
| Oct. 15, 2025 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 234 | $31.17 | 1,848,102.0000 | 124,851,547 | 0.01% | 0.00% |
| Oct. 15, 2025 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 46 | $31.17 | 82,836.0000 | 124,851,547 | 0.06% | 0.00% |
| Oct. 16, 2025 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 111041 | $29.32 | 1,737,061.0000 | 124,851,547 | 6.01% | 0.09% |
| Oct. 16, 2025 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 21804 | $29.32 | 61,032.0000 | 124,851,547 | 26.32% | 0.02% |
| Oct. 16, 2025 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 15826 | $30.36 | 1,721,235.0000 | 124,851,547 | 0.91% | 0.01% |
| Sept. 26, 2025 | PepGen Inc. | $PEPG | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 9375000 | $3.20 | 20,064,545.0000 | 32,692,388 | 87.70% | 28.68% |
| Sept. 18, 2025 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Pre-Funded Warrant (Right to Buy) | 10000000 | $5.00 | 10,000,000.0000 | 124,851,547 | 9999.99% | 8.01% |
| Sept. 8, 2025 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 124,851,547 | 9999.99% | 0.05% |
| Sept. 4, 2025 | Mineralys Therapeutics, Inc. | $MLYS | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 1176470 | $25.50 | 7,323,750.0000 | 49,835,637 | 19.14% | 2.36% |
| Aug. 11, 2025 | Wave Life Sciences Ltd. | $WVE | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Share Option (Right to Buy) | 76200 | $0.00 | 76,200.0000 | 138,277,468 | 9999.99% | 0.06% |
| Aug. 11, 2025 | Wave Life Sciences Ltd. | $WVE | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Ordinary Shares | 12700 | $0.00 | 18,230,824.0000 | 138,277,468 | 0.07% | 0.01% |
| June 26, 2025 | Cidara Therapeutics, Inc. | $CDTX | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 2272727 | $44.00 | 3,365,523.0000 | 10,953,490 | 207.97% | 20.75% |
| June 25, 2025 | ARS Pharmaceuticals, Inc. | $SPRY | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 102,390,828 | 9999.99% | 0.03% |
| June 24, 2025 | Artiva Biotherapeutics, Inc. | $ARTV | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Director Stock Option (Right to Buy) | 13750 | $0.00 | 13,750.0000 | 24,363,119 | 9999.99% | 0.06% |
| June 17, 2025 | Septerna, Inc. | $SEPN | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 16623 | $0.00 | 16,623.0000 | 9,891,126 | 9999.99% | 0.17% |
| June 18, 2025 | Cidara Therapeutics, Inc. | $CDTX | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (right to buy) | 5079 | $0.00 | 5,079.0000 | 10,953,490 | 9999.99% | 0.05% |
| June 13, 2025 | Acrivon Therapeutics, Inc. | $ACRV | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 20275 | $0.00 | 20,275.0000 | 33,791,817 | 9999.99% | 0.06% |
| June 13, 2025 | Tyra Biosciences, Inc. | $TYRA | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 120167 | $10.20 | 12,186,812.0000 | 57,217,746 | 1.00% | 0.21% |
| June 16, 2025 | Tyra Biosciences, Inc. | $TYRA | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 11813 | $10.13 | 12,198,625.0000 | 57,217,746 | 0.10% | 0.02% |
| June 12, 2025 | Tyra Biosciences, Inc. | $TYRA | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 31307 | $10.20 | 12,066,645.0000 | 57,217,746 | 0.26% | 0.05% |
| June 12, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Non-Qualified Stock Option (right to buy) | 19959 | $0.00 | 19,959.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2025 | Janux Therapeutics, Inc. | $JANX | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Common Stock | 3750 | $0.00 | 11,195,943.0000 | 53,751,480 | 0.03% | 0.01% |
| June 11, 2025 | Janux Therapeutics, Inc. | $JANX | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 11667 | $0.00 | 11,667.0000 | 53,751,480 | 9999.99% | 0.02% |
| June 9, 2025 | Tyra Biosciences, Inc. | $TYRA | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 186850 | $10.19 | 12,035,338.0000 | 57,217,746 | 1.58% | 0.33% |
| June 11, 2025 | LENZ Therapeutics, Inc. | $LENZ | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (right to buy) | 13500 | $0.00 | 13,500.0000 | 27,542,874 | 9999.99% | 0.05% |
| June 9, 2025 | Bicara Therapeutics Inc. | $BCAX | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 23746 | $0.00 | 23,746.0000 | 16,805,524,000 | 9999.99% | 0.00% |
| June 5, 2025 | Nkarta, Inc. | $NKTX | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (right to buy) | 46000 | $0.00 | 46,000.0000 | 67,865,323 | 9999.99% | 0.07% |
| June 5, 2025 | Tyra Biosciences, Inc. | $TYRA | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 213334 | $10.04 | 11,848,488.0000 | 57,217,746 | 1.83% | 0.37% |
| June 4, 2025 | PepGen Inc. | $PEPG | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 16000 | $0.00 | 16,000.0000 | 32,692,388 | 9999.99% | 0.05% |
| June 4, 2025 | Tyra Biosciences, Inc. | $TYRA | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 997864 | $9.63 | 11,635,154.0000 | 57,217,746 | 9.38% | 1.74% |
| June 4, 2025 | Acumen Pharmaceuticals, Inc. | $ABOS | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 19500 | $0.00 | 19,500.0000 | 60,573,425 | 9999.99% | 0.03% |
| June 4, 2025 | Climb Bio, Inc. | $CLYM | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 67,475,395 | 9999.99% | 0.06% |
| June 4, 2025 | Acumen Pharmaceuticals, Inc. | $ABOS | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Common Stock | 12800 | $0.00 | 14,944,863.0000 | 60,573,425 | 0.09% | 0.02% |
| May 29, 2025 | Tyra Biosciences, Inc. | $TYRA | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 22200 | $0.00 | 22,200.0000 | 57,217,746 | 9999.99% | 0.04% |
| May 22, 2025 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 124,851,547 | 9999.99% | 0.02% |
| May 14, 2025 | Werewolf Therapeutics, Inc. | $HOWL | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 162539 | $0.98 | 6,681,307.0000 | 44,827,159 | 2.49% | 0.36% |
| May 12, 2025 | Werewolf Therapeutics, Inc. | $HOWL | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 320913 | $0.86 | 6,465,794.0000 | 44,827,159 | 5.22% | 0.72% |
| May 13, 2025 | Werewolf Therapeutics, Inc. | $HOWL | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 52974 | $0.98 | 6,518,768.0000 | 44,827,159 | 0.82% | 0.12% |
| April 28, 2025 | Jade Biosciences, Inc. | $JBIO | RA CAPITAL MANAGEMENT, L.P. | Not found | J | Common Stock | 1062326 | $0.00 | 1,324,954.0000 | 0 | 404.50% | 0.00% |
| March 13, 2025 | Mineralys Therapeutics, Inc. | $MLYS | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 1296296 | $13.50 | 6,147,280.0000 | 49,835,637 | 26.72% | 2.60% |
| March 7, 2025 | Janux Therapeutics, Inc. | $JANX | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 110206 | $31.02 | 11,189,693.0000 | 53,751,480 | 0.99% | 0.21% |
| March 6, 2025 | Janux Therapeutics, Inc. | $JANX | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 372093 | $30.78 | 11,079,487.0000 | 53,751,480 | 3.48% | 0.69% |
| March 5, 2025 | Janux Therapeutics, Inc. | $JANX | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 304287 | $30.56 | 10,669,939.0000 | 53,751,480 | 2.94% | 0.57% |
| March 5, 2025 | Janux Therapeutics, Inc. | $JANX | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 37455 | $31.30 | 10,707,394.0000 | 53,751,480 | 0.35% | 0.07% |
| Feb. 13, 2025 | Mineralys Therapeutics, Inc. | $MLYS | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 32900 | $0.00 | 32,900.0000 | 49,835,637 | 9999.99% | 0.07% |
| Feb. 19, 2025 | Solid Biosciences Inc. | $SLDB | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Pre-Funded Warrants (Right to Buy) | 3722085 | $4.03 | 3,722,085.0000 | 40,816,694 | 9999.99% | 9.12% |
| Feb. 10, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 1022586 | $18.00 | 6,923,365.0000 | 0 | 17.33% | 0.00% |
| Feb. 10, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Common Stock | 5021990 | $0.00 | 5,900,779.0000 | 0 | 571.47% | 0.00% |
| Feb. 10, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Common Stock | 527444 | $0.00 | 869,651.0000 | 0 | 154.13% | 0.00% |
| Feb. 10, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Common Stock | 2222084 | $0.00 | 2,222,084.0000 | 0 | 9999.99% | 0.00% |
| Feb. 10, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Common Stock | 179975 | $0.00 | 327,808.0000 | 0 | 121.74% | 0.00% |
| Feb. 10, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 102414 | $18.00 | 2,324,498.0000 | 0 | 4.61% | 0.00% |
| Feb. 10, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series Seed Preferred Stock | 819153 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 10, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series Seed Preferred Stock | 319069 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 10, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series Seed Preferred Stock | 138054 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 10, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series A Preferred Stock | 1229830 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 10, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series A Preferred Stock | 451580 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 10, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series A Preferred Stock | 124908 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 10, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series B Preferred Stock | 923773 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 10, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series B Preferred Stock | 2155469 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 10, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series C Preferred Stock | 4364874 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 10, 2025 | Sionna Therapeutics, Inc. | $SION | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series C Preferred Stock | 1091219 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 3, 2025 | 89bio, Inc. | $ETNB | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 56400 | $0.00 | 56,400.0000 | 104,714,613 | 9999.99% | 0.05% |
| Jan. 30, 2025 | 89bio, Inc. | $ETNB | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 5714285 | $8.75 | 19,889,683.0000 | 104,714,613 | 40.31% | 5.46% |
| Jan. 3, 2025 | Cidara Therapeutics, Inc. | $CDTX | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (right to buy) | 22200 | $0.00 | 22,200.0000 | 0 | 9999.99% | 0.00% |
| Dec. 30, 2024 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Common Stock | 16897159 | $0.00 | 39,646,039.0000 | 0 | 74.28% | 0.00% |
| Dec. 30, 2024 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Warrant (Right to Buy) | 21121449 | $0.00 | 21,121,449.0000 | 0 | 9999.99% | 0.00% |
| Dec. 9, 2024 | 4D Molecular Therapeutics, Inc. | $FDMT | RA CAPITAL MANAGEMENT, L.P. | Not found | J | Common Stock | 535000 | $0.00 | 4,563,211.0000 | 0 | 10.49% | 0.00% |
| Dec. 9, 2024 | 4D Molecular Therapeutics, Inc. | $FDMT | RA CAPITAL MANAGEMENT, L.P. | Not found | J | Pre-Funded Warrants (Right to Buy) | 535000 | $0.00 | 3,610,000.0000 | 0 | 17.40% | 0.00% |
| Nov. 26, 2024 | Cidara Therapeutics, Inc. | $CDTX | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Pre-Funded Warrants (Right to Buy) | 1286786 | $14.91 | 1,286,786.0000 | 0 | 9999.99% | 0.00% |
| Nov. 26, 2024 | Cidara Therapeutics, Inc. | $CDTX | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Common Stock | 389716 | $14.91 | 1,092,796.0000 | 0 | 55.43% | 0.00% |
| Nov. 14, 2024 | 89bio, Inc. | $ETNB | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Pre-Funded Warrants (Right to Buy) | 3250000 | $8.50 | 4,331,081.0000 | 99,831,111 | 300.63% | 3.26% |
| Nov. 8, 2024 | Tyra Biosciences, Inc. | $TYRA | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 1220681 | $16.25 | 10,637,290.0000 | 58,874,497 | 12.96% | 2.07% |
| Oct. 28, 2024 | Septerna, Inc. | $SEPN | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Common Stock | 1130343 | $0.00 | 1,130,343.0000 | 2,443,678 | 9999.99% | 46.26% |
| Oct. 28, 2024 | Septerna, Inc. | $SEPN | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Common Stock | 1695515 | $0.00 | 1,695,515.0000 | 2,443,678 | 9999.99% | 69.38% |
| Oct. 28, 2024 | Septerna, Inc. | $SEPN | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series B Preferred Stock | 14598896 | $0.00 | 0.0000 | 2,443,678 | 100.00% | 100.00% |
| Oct. 28, 2024 | Septerna, Inc. | $SEPN | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series B Preferred Stock | 9732596 | $0.00 | 0.0000 | 2,443,678 | 100.00% | 100.00% |
| Oct. 28, 2024 | Septerna, Inc. | $SEPN | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 3828400 | $18.00 | 5,523,915.0000 | 2,443,678 | 225.80% | 100.00% |
| Oct. 28, 2024 | Septerna, Inc. | $SEPN | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 341600 | $18.00 | 1,471,943.0000 | 2,443,678 | 30.22% | 13.98% |
| Oct. 18, 2024 | Tyra Biosciences, Inc. | $TYRA | RA CAPITAL MANAGEMENT, L.P. | Not found | J | Common Stock | 1000000 | $0.00 | 9,416,609.0000 | 58,874,497 | 9.60% | 1.70% |
| Oct. 18, 2024 | Tyra Biosciences, Inc. | $TYRA | RA CAPITAL MANAGEMENT, L.P. | Not found | J | Pre-Funded Warrants (Right to Buy) | 2358457 | $0.00 | 1,000,000.0000 | 58,874,497 | 0.00% | 4.01% |
| Oct. 18, 2024 | Janux Therapeutics, Inc. | $JANX | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 1200000 | $44.75 | 10,365,652.0000 | 54,628,670 | 13.09% | 2.20% |
| Sept. 16, 2024 | Bicara Therapeutics Inc. | $BCAX | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Common Stock | 2622898 | $0.00 | 2,622,898.0000 | 580,109,000 | 9999.99% | 0.45% |
| Sept. 16, 2024 | Bicara Therapeutics Inc. | $BCAX | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Common Stock | 2500095 | $0.00 | 2,500,095.0000 | 580,109,000 | 9999.99% | 0.43% |
| Sept. 16, 2024 | Bicara Therapeutics Inc. | $BCAX | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 1680520 | $18.00 | 4,303,418.0000 | 580,109,000 | 64.07% | 0.29% |
| Sept. 16, 2024 | Bicara Therapeutics Inc. | $BCAX | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 152480 | $18.00 | 2,652,575.0000 | 580,109,000 | 6.10% | 0.03% |
| Sept. 16, 2024 | Bicara Therapeutics Inc. | $BCAX | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series B Preferred Stock | 18409755 | $0.00 | 0.0000 | 580,109,000 | 100.00% | 3.17% |
| Sept. 16, 2024 | Bicara Therapeutics Inc. | $BCAX | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series B Preferred Stock | 12273169 | $0.00 | 0.0000 | 580,109,000 | 100.00% | 2.12% |
| Sept. 16, 2024 | Bicara Therapeutics Inc. | $BCAX | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series C Preferred Stock | 5835024 | $0.00 | 0.0000 | 580,109,000 | 100.00% | 1.01% |
| Sept. 16, 2024 | Bicara Therapeutics Inc. | $BCAX | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series C Preferred Stock | 10836474 | $0.00 | 0.0000 | 580,109,000 | 100.00% | 1.87% |
| Sept. 12, 2024 | Bicara Therapeutics Inc. | $BCAX | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 23746 | $0.00 | 23,746.0000 | 580,109,000 | 9999.99% | 0.00% |
| Aug. 21, 2024 | Fulcrum Therapeutics, Inc. | $FULC | RA CAPITAL MANAGEMENT, L.P. | Not found | J | Common Stock | 8500000 | $0.00 | 3,109,704.0000 | 61,310 | 73.21% | 100.00% |
| Aug. 21, 2024 | Fulcrum Therapeutics, Inc. | $FULC | RA CAPITAL MANAGEMENT, L.P. | Not found | J | Warrant (Right to Buy) | 8500000 | $0.00 | 8,500,000.0000 | 61,310 | 9999.99% | 100.00% |
| Aug. 12, 2024 | Wave Life Sciences Ltd. | $WVE | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Ordinary Shares | 16115 | $0.00 | 18,218,124.0000 | 106,097,268 | 0.09% | 0.02% |
| Aug. 12, 2024 | Wave Life Sciences Ltd. | $WVE | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Share Option (Right to Buy) | 32230 | $0.00 | 32,230.0000 | 106,097,268 | 9999.99% | 0.03% |
| Aug. 9, 2024 | AN2 Therapeutics, Inc. | $ANTX | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 3410335 | $1.08 | 1,725,348.0000 | 23,600,107 | 66.40% | 14.45% |
| Aug. 9, 2024 | AN2 Therapeutics, Inc. | $ANTX | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 114759 | $1.08 | 300,853.0000 | 23,600,107 | 27.61% | 0.49% |
| July 22, 2024 | Artiva Biotherapeutics, Inc. | $ARTV | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series B Preferred Stock | 161019 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| July 22, 2024 | Artiva Biotherapeutics, Inc. | $ARTV | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series B Preferred Stock | 53673 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| July 22, 2024 | Artiva Biotherapeutics, Inc. | $ARTV | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series A Preferred Stock | 68320 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| July 22, 2024 | Artiva Biotherapeutics, Inc. | $ARTV | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series A Preferred Stock | 210898 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| July 22, 2024 | Artiva Biotherapeutics, Inc. | $ARTV | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series A Preferred Stock | 564372 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| July 22, 2024 | Artiva Biotherapeutics, Inc. | $ARTV | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 688326 | $12.00 | 826,832.0000 | 0 | 496.96% | 0.00% |
| July 22, 2024 | Artiva Biotherapeutics, Inc. | $ARTV | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 7645007 | $12.00 | 8,693,579.0000 | 0 | 729.09% | 0.00% |
| July 22, 2024 | Artiva Biotherapeutics, Inc. | $ARTV | RA CAPITAL MANAGEMENT, L.P. | Not found | J | Common Stock | 138506 | $10.20 | 138,506.0000 | 0 | 9999.99% | 0.00% |
| July 22, 2024 | Artiva Biotherapeutics, Inc. | $ARTV | RA CAPITAL MANAGEMENT, L.P. | Not found | J | Common Stock | 323181 | $10.20 | 1,048,572.0000 | 0 | 44.55% | 0.00% |
| July 22, 2024 | Artiva Biotherapeutics, Inc. | $ARTV | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Common Stock | 68320 | $0.00 | 68,320.0000 | 0 | 9999.99% | 0.00% |
| July 22, 2024 | Artiva Biotherapeutics, Inc. | $ARTV | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Common Stock | 264571 | $0.00 | 264,571.0000 | 0 | 9999.99% | 0.00% |
| July 22, 2024 | Artiva Biotherapeutics, Inc. | $ARTV | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Common Stock | 725391 | $0.00 | 725,391.0000 | 0 | 9999.99% | 0.00% |
| July 18, 2024 | Cidara Therapeutics, Inc. | $CDTX | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (right to buy) | 2125 | $0.00 | 2,125.0000 | 0 | 9999.99% | 0.00% |
| July 18, 2024 | Cidara Therapeutics, Inc. | $CDTX | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Series A Preferred Stock | 100000 | $1000.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| July 19, 2024 | Cidara Therapeutics, Inc. | $CDTX | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series A Preferred Stock | 10044 | $0.00 | 89,956.0000 | 0 | 10.04% | 0.00% |
| July 19, 2024 | Cidara Therapeutics, Inc. | $CDTX | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Common Stock | 703080 | $0.00 | 703,080.0000 | 0 | 9999.99% | 0.00% |
| July 18, 2024 | Cidara Therapeutics, Inc. | $CDTX | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (right to buy) | 2125 | $0.00 | 2,125.0000 | 0 | 9999.99% | 0.00% |
| June 27, 2024 | Climb Bio, Inc. | $CLYM | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Common Stock | 1807000 | $0.00 | 4,358,263.0000 | 0 | 70.83% | 0.00% |
| June 27, 2024 | Climb Bio, Inc. | $CLYM | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Common Stock | 973000 | $0.00 | 14,123,849.0000 | 0 | 7.40% | 0.00% |
| June 27, 2024 | Climb Bio, Inc. | $CLYM | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 1059375 | $3.84 | 5,417,638.0000 | 0 | 24.31% | 0.00% |
| June 27, 2024 | Climb Bio, Inc. | $CLYM | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 11949171 | $3.84 | 26,073,020.0000 | 0 | 84.60% | 0.00% |
| June 27, 2024 | Climb Bio, Inc. | $CLYM | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Common Stock | 2479872 | $0.00 | 5,031,135.0000 | 0 | 97.20% | 0.00% |
| June 26, 2024 | Climb Bio, Inc. | $CLYM | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| June 26, 2024 | Janux Therapeutics, Inc. | $JANX | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 8350 | $0.00 | 8,350.0000 | 44,016,283 | 9999.99% | 0.02% |
| June 26, 2024 | Janux Therapeutics, Inc. | $JANX | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Common Stock | 2500 | $0.00 | 9,168,152.0000 | 44,016,283 | 0.03% | 0.01% |
| June 20, 2024 | Acrivon Therapeutics, Inc. | $ACRV | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 20275 | $0.00 | 20,275.0000 | 22,078,190 | 9999.99% | 0.09% |
| June 20, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 95,215,322 | 9999.99% | 0.04% |
| June 20, 2024 | PepGen Inc. | $PEPG | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 13000 | $0.00 | 13,000.0000 | 0 | 9999.99% | 0.00% |
| June 17, 2024 | Jade Biosciences, Inc. | $JBIO | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 928110 | $1.67 | 9,192,092.0000 | 0 | 11.23% | 0.00% |
| June 13, 2024 | Nkarta, Inc. | $NKTX | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (right to buy) | 22500 | $0.00 | 22,500.0000 | 49,014,300 | 9999.99% | 0.05% |
| June 10, 2024 | Acumen Pharmaceuticals, Inc. | $ABOS | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2024 | Jade Biosciences, Inc. | $JBIO | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 12500 | $0.00 | 12,500.0000 | 0 | 9999.99% | 0.00% |
| May 29, 2024 | Tyra Biosciences, Inc. | $TYRA | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (right to buy) | 18600 | $0.00 | 18,600.0000 | 42,704,876 | 9999.99% | 0.04% |
| May 23, 2024 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| May 22, 2024 | Mineralys Therapeutics, Inc. | $MLYS | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option | 22000 | $0.00 | 22,000.0000 | 0 | 9999.99% | 0.00% |
| May 24, 2024 | Werewolf Therapeutics, Inc. | $HOWL | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (right to buy) | 17500 | $0.00 | 17,500.0000 | 0 | 9999.99% | 0.00% |
| May 10, 2024 | iTeos Therapeutics, Inc. | $ITOS | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Pre- Funded Warrants (Right to Buy) | 5714285 | $17.50 | 5,714,285.0000 | 0 | 9999.99% | 0.00% |
| May 12, 2024 | iTeos Therapeutics, Inc. | $ITOS | RA CAPITAL MANAGEMENT, L.P. | Not found | J | Pre- Funded Warrants (Right to Buy) | 900000 | $0.00 | 6,614,285.0000 | 0 | 15.75% | 0.00% |
| May 12, 2024 | iTeos Therapeutics, Inc. | $ITOS | RA CAPITAL MANAGEMENT, L.P. | Not found | J | Common Stock | 900000 | $0.00 | 3,517,259.0000 | 0 | 20.37% | 0.00% |
| April 26, 2024 | Cidara Therapeutics, Inc. | $CDTX | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (right to buy) | 4250 | $0.00 | 4,250.0000 | 0 | 9999.99% | 0.00% |
| April 11, 2024 | 89bio, Inc. | $ETNB | RA CAPITAL MANAGEMENT, L.P. | Not found | X | Common Stock | 1408450 | $5.33 | 14,175,398.0000 | 71,172,870 | 11.03% | 1.98% |
| April 11, 2024 | 89bio, Inc. | $ETNB | RA CAPITAL MANAGEMENT, L.P. | Not found | X | Warrants (Right to Buy) | 2816900 | $0.00 | 0.0000 | 71,172,870 | 100.00% | 3.96% |
| Feb. 1, 2024 | 89bio, Inc. | $ETNB | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 45150 | $0.00 | 45,150.0000 | 71,172,870 | 9999.99% | 0.06% |
| Feb. 9, 2023 | 89bio, Inc. | $ETNB | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 27400 | $0.00 | 27,400.0000 | 34,806,349 | 9999.99% | 0.08% |
| April 11, 2024 | Acrivon Therapeutics, Inc. | $ACRV | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Common Stock | 3530000 | $8.50 | 8,340,508.0000 | 22,078,190 | 73.38% | 15.99% |
| April 2, 2024 | Boundless Bio, Inc. | $BOLD | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series B Preferred Stock | 3000000 | $0.00 | 0.0000 | 1,248 | 100.00% | 100.00% |
| April 2, 2024 | Boundless Bio, Inc. | $BOLD | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Common Stock | 1587912 | $0.00 | 1,587,912.0000 | 1,248 | 9999.99% | 100.00% |
| April 2, 2024 | Boundless Bio, Inc. | $BOLD | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 296875 | $16.00 | 1,884,787.0000 | 1,248 | 18.70% | 100.00% |
| April 2, 2024 | Boundless Bio, Inc. | $BOLD | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Common Stock | 280219 | $0.00 | 280,219.0000 | 1,248 | 9999.99% | 100.00% |
| April 2, 2024 | Boundless Bio, Inc. | $BOLD | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 15625 | $16.00 | 295,844.0000 | 1,248 | 5.58% | 100.00% |
| April 2, 2024 | Boundless Bio, Inc. | $BOLD | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series B Preferred Stock | 17000000 | $0.00 | 0.0000 | 1,248 | 100.00% | 100.00% |
| April 2, 2024 | Boundless Bio, Inc. | $BOLD | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series C Preferred Stock | 2464286 | $0.00 | 0.0000 | 1,248 | 100.00% | 100.00% |
| April 2, 2024 | Boundless Bio, Inc. | $BOLD | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series C Preferred Stock | 13964285 | $0.00 | 0.0000 | 1,248 | 100.00% | 100.00% |
| March 27, 2024 | Nkarta, Inc. | $NKTX | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Pre- Funded Warrants (Right to Buy) | 3000031 | $10.00 | 3,000,031.0000 | 49,014,300 | 9999.99% | 6.12% |
| March 27, 2024 | Nkarta, Inc. | $NKTX | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 3000000 | $10.00 | 10,805,129.0000 | 49,014,300 | 38.44% | 6.12% |
| March 26, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 457745 | $9.55 | 10,355,023.0000 | 95,215,322 | 4.62% | 0.48% |
| March 25, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 437600 | $9.06 | 9,897,278.0000 | 95,215,322 | 4.63% | 0.46% |
| March 27, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 505954 | $9.79 | 10,860,977.0000 | 95,215,322 | 4.89% | 0.53% |
| March 21, 2024 | LENZ Therapeutics, Inc. | $LENZ | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Common Stock | 694755 | $0.00 | 4,014,094.0000 | 0 | 20.93% | 0.00% |
| March 21, 2024 | LENZ Therapeutics, Inc. | $LENZ | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Common Stock | 2386301 | $0.00 | 5,705,640.0000 | 0 | 71.89% | 0.00% |
| March 21, 2024 | LENZ Therapeutics, Inc. | $LENZ | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (right to buy) | 27000 | $0.00 | 27,000.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | LENZ Therapeutics, Inc. | $LENZ | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Warrants (Right to Buy) | 10580 | $0.00 | 10,580.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | LENZ Therapeutics, Inc. | $LENZ | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Warrants (Right to Buy) | 54582 | $0.00 | 54,582.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | LENZ Therapeutics, Inc. | $LENZ | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stockj | 64971 | $15.03 | 694,755.0000 | 0 | 10.32% | 0.00% |
| March 21, 2024 | LENZ Therapeutics, Inc. | $LENZ | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 933038 | $15.03 | 4,014,094.0000 | 0 | 30.28% | 0.00% |
| March 21, 2024 | LENZ Therapeutics, Inc. | $LENZ | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Common Stock | 164729 | $0.00 | 859,484.0000 | 0 | 23.71% | 0.00% |
| March 21, 2024 | LENZ Therapeutics, Inc. | $LENZ | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Warrants (Right to Buy) | 5371 | $0.00 | 5,371.0000 | 0 | 9999.99% | 0.00% |
| March 4, 2024 | Janux Therapeutics, Inc. | $JANX | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Pre-Funded Warrants (Right to Buy) | 1397849 | $46.50 | 1,397,849.0000 | 44,016,283 | 9999.99% | 3.18% |
| March 4, 2024 | 89bio, Inc. | $ETNB | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 1350000 | $15.35 | 12,766,948.0000 | 71,172,870 | 11.82% | 1.90% |
| Feb. 12, 2024 | Mineralys Therapeutics, Inc. | $MLYS | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Pre-Funded Warrants (Right to Buy) | 549755 | $13.50 | 549,755.0000 | 0 | 9999.99% | 0.00% |
| Feb. 12, 2024 | Mineralys Therapeutics, Inc. | $MLYS | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Common Stock | 1672508 | $13.50 | 4,850,984.0000 | 0 | 52.62% | 0.00% |
| Feb. 9, 2024 | PepGen Inc. | $PEPG | RA CAPITAL MANAGEMENT, L.P. | Director | P | Common Stock | 2557593 | $10.64 | 10,689,545.0000 | 0 | 31.45% | 0.00% |
| Feb. 6, 2024 | Tyra Biosciences, Inc. | $TYRA | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Common Stock | 3180155 | $13.01 | 10,416,609.0000 | 42,704,876 | 43.95% | 7.45% |
| Feb. 6, 2024 | Tyra Biosciences, Inc. | $TYRA | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Pre-Funded Warrants (Right to Buy) | 1538457 | $13.01 | 1,538,457.0000 | 42,704,876 | 9999.99% | 3.60% |
| Dec. 11, 2023 | Wave Life Sciences Ltd. | $WVE | RA CAPITAL MANAGEMENT, L.P. | Director | P | Common Stock | 1000000 | $5.00 | 18,202,009.0000 | 78,855,810 | 5.81% | 1.27% |
| Jan. 11, 2024 | Solid Biosciences Inc. | $SLDB | RA CAPITAL MANAGEMENT, L.P. | Director | P | Common Stock | 904160 | $5.53 | 4,301,877.0000 | 19,884,007 | 26.61% | 4.55% |
| Dec. 11, 2023 | Wave Life Sciences Ltd. | $WVE | RA CAPITAL MANAGEMENT, L.P. | Director | P | Common Stock | 1000000 | $5.00 | 19,202,009.0000 | 78,855,810 | 5.49% | 1.27% |
| Dec. 11, 2023 | 89bio, Inc. | $ETNB | RA CAPITAL MANAGEMENT, L.P. | Director | P | Pre-Funded Warrants (Right to Buy) | 1081081 | $9.25 | 1,081,081.0000 | 34,806,349 | 9999.99% | 3.11% |
| Sept. 21, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | RA CAPITAL MANAGEMENT, L.P. | Director | P | Common Stock | 2508691 | $2.97 | 9,268,369.0000 | 0 | 37.11% | 0.00% |
| Sept. 21, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | RA CAPITAL MANAGEMENT, L.P. | Director | P | Common Stock | 191309 | $3.83 | 9,459,678.0000 | 0 | 2.06% | 0.00% |
| Aug. 29, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | RA CAPITAL MANAGEMENT, L.P. | Director | P | Common Stock | 3750000 | $6.20 | 6,759,678.0000 | 0 | 124.60% | 0.00% |
| Aug. 18, 2023 | AN2 Therapeutics, Inc. | $ANTX | RA CAPITAL MANAGEMENT, L.P. | TenPercentOwner | P | Common Stock | 1777778 | $9.00 | 5,551,295.0000 | 0 | 47.11% | 0.00% |
| Aug. 7, 2023 | Wave Life Sciences Ltd. | $WVE | RA CAPITAL MANAGEMENT, L.P. | Director | A | Share Option (Right to Buy) | 45000 | $0.00 | 45,000.0000 | 78,855,810 | 9999.99% | 0.06% |
| July 21, 2023 | Acumen Pharmaceuticals, Inc. | $ABOS | RA CAPITAL MANAGEMENT, L.P. | Director | P | Common Stock | 5161290 | $7.75 | 14,932,063.0000 | 0 | 52.82% | 0.00% |
| June 27, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | RA CAPITAL MANAGEMENT, L.P. | Director | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| June 21, 2023 | Werewolf Therapeutics, Inc. | $HOWL | RA CAPITAL MANAGEMENT, L.P. | Director | A | Stock Option (Right to Buy) | 13200 | $0.00 | 13,200.0000 | 0 | 50.00% | 0.00% |
| June 6, 2023 | Acumen Pharmaceuticals, Inc. | $ABOS | RA CAPITAL MANAGEMENT, L.P. | Director | A | Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 0 | 50.00% | 0.00% |
| May 26, 2023 | Vor Biopharma Inc. | $VOR | RA CAPITAL MANAGEMENT, L.P. | Director | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| May 18, 2023 | Climb Bio, Inc. | $CLYM | RA CAPITAL MANAGEMENT, L.P. | Director | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| March 24, 2023 | 89bio, Inc. | $ETNB | RA CAPITAL MANAGEMENT, L.P. | Director | P | Common Stock | 2461538 | $16.25 | 11,416,948.0000 | 34,806,349 | 27.49% | 7.07% |
| Feb. 23, 2023 | Enliven Therapeutics, Inc. | $ELVN | RA CAPITAL MANAGEMENT, L.P. | Other | A | Common Stock | 1152460 | $0.00 | 2,122,465.0000 | 0 | 118.81% | 0.00% |
| Feb. 14, 2023 | Mineralys Therapeutics, Inc. | $MLYS | RA CAPITAL MANAGEMENT, L.P. | Director | C | Series B Preferred Stock | 1735629 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 14, 2023 | Mineralys Therapeutics, Inc. | $MLYS | RA CAPITAL MANAGEMENT, L.P. | Director | P | Common Stock | 1118400 | $16.00 | 1,311,247.0000 | 0 | 579.94% | 0.00% |
| Feb. 14, 2023 | Mineralys Therapeutics, Inc. | $MLYS | RA CAPITAL MANAGEMENT, L.P. | Director | C | Common Stock | 192847 | $0.00 | 192,847.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2023 | Mineralys Therapeutics, Inc. | $MLYS | RA CAPITAL MANAGEMENT, L.P. | Director | P | Common Stock | 131600 | $16.00 | 1,867,229.0000 | 0 | 7.58% | 0.00% |
| Feb. 14, 2023 | Mineralys Therapeutics, Inc. | $MLYS | RA CAPITAL MANAGEMENT, L.P. | Director | C | Common Stock | 1735629 | $0.00 | 1,735,629.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2023 | Mineralys Therapeutics, Inc. | $MLYS | RA CAPITAL MANAGEMENT, L.P. | Director | C | Series B Preferred Stock | 192847 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 9, 2023 | Mineralys Therapeutics, Inc. | $MLYS | RA CAPITAL MANAGEMENT, L.P. | Director | A | Stock Option | 44000 | $0.00 | 44,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 6, 2023 | Werewolf Therapeutics, Inc. | $HOWL | RA CAPITAL MANAGEMENT, L.P. | Director | P | Common Stock | 1853000 | $2.21 | 6,144,881.0000 | 0 | 43.17% | 0.00% |
| Jan. 3, 2023 | Enliven Therapeutics, Inc. | $ELVN | RA CAPITAL MANAGEMENT, L.P. | TenPercentOwner | P | Common Stock | 629297 | $4.00 | 3,880,021.0000 | 0 | 19.36% | 0.00% |